These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 39197442)

  • 1. [Neuromuscular Blockade in the Critically Ill].
    Jung C; Stüber T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2024 Aug; 59(9):506-516. PubMed ID: 39197442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular blocking agents in the intensive care unit.
    Rodríguez-Blanco J; Rodríguez-Yanez T; Rodríguez-Blanco JD; Almanza-Hurtado AJ; Martínez-Ávila MC; Borré-Naranjo D; Acuña Caballero MC; Dueñas-Castell C
    J Int Med Res; 2022 Sep; 50(9):3000605221128148. PubMed ID: 36173012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?
    Puthucheary Z; Rawal J; Ratnayake G; Harridge S; Montgomery H; Hart N
    Am J Respir Crit Care Med; 2012 May; 185(9):911-7. PubMed ID: 22550208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular blockade management in the critically Ill patient.
    Renew JR; Ratzlaff R; Hernandez-Torres V; Brull SJ; Prielipp RC
    J Intensive Care; 2020; 8():37. PubMed ID: 32483489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest.
    May TL; Riker RR; Fraser GL; Hirsch KG; Agarwal S; Duarte C; Friberg H; Søreide E; McPherson J; Hand R; Kent D; Nielsen N; Seder DB
    Crit Care Med; 2018 Oct; 46(10):e975-e980. PubMed ID: 29979225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedation and neuromuscular blockade in patients with acute respiratory failure.
    Luer JM
    Crit Care Nurse; 2000 Oct; 20(5):84-9. PubMed ID: 11878492
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 14. Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade.
    Bass S; Vance ML; Reddy A; Bauer SR; Roach E; Torbic H; Welch S; Duggal A
    Am J Crit Care; 2019 Sep; 28(5):377-384. PubMed ID: 31474608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Be Flat Dose.
    Co I; Hyzy RC
    Crit Care Med; 2020 Apr; 48(4):591-593. PubMed ID: 32205607
    [No Abstract]   [Full Text] [Related]  

  • 17. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 18. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Not Be Flat Dose.
    Flannery AH; Moss M
    Crit Care Med; 2020 Apr; 48(4):588-590. PubMed ID: 32205606
    [No Abstract]   [Full Text] [Related]  

  • 19. What Is the Evidence for Harm of Neuromuscular Blockade and Corticosteroid Use in the Intensive Care Unit?
    Annane D
    Semin Respir Crit Care Med; 2016 Feb; 37(1):51-6. PubMed ID: 26820274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedation and neuromuscular blockade in paediatric intensive care; practice in the United Kingdom and North America.
    Crean P
    Paediatr Anaesth; 2004 Jun; 14(6):439-42. PubMed ID: 15153203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.